Has Chih-Chun Lin, MD received payments from drug or device companies?

Yes. Drug and device makers reported $46,838 in general payments to Chih-Chun Lin, MD across 25 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Chih-Chun Lin, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Chih-Chun Lin, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Chih-Chun Lin, MD

Neurology · New York, NYNPI 1366837668

Payments from drug & device makers

What this record shows

This record is dominated by grants: $45,000 of the $46,838 with a category attached, or 96.1%. Medtronic accounts for 74.7% of it on its own, with 9 other manufacturers making up the rest. Reporting peaked in 2019 at $25,269 and has fallen 94.2% since, to $1,462 in 2023. Among neurology clinicians in NY with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$46,838in general payments, 2019–2025

Across 25 payments — averaging $1873.50 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Medtronic$35K
Boston Scientific$10K
Sage Therapeutics, LLC$2K
Sanofi$80
Avanir Pharmaceuticals, Inc.$54
Acorda Therapeutics, Inc$45
plus $97 from 4 others

$36,299in research payments, 2019–2025

Across 2 payments — averaging $18,150 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Sage Therapeutics, LLC$36K

What the payments were for

Speaking & faculty fees$450%
Grants$45,00096%
Travel & lodging$1,0142%
Food & beverage$7792%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Medtronic	2	$35,000
Boston Scientific	2	$10,023
Sage Therapeutics, LLC	6	$1,539
Sanofi	4	$80
Avanir Pharmaceuticals, Inc.	3	$54
Acorda Therapeutics, Inc	2	$45
Genentech USA, Inc.	2	$31
Acadia Pharmaceuticals Inc	2	$29
Amgen	1	$20
Johnson & Johnson	1	$17

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

ACTIVA$35,000
VERCISE$10,000

How this compares

$46,838 in reported general payments places this provider in the 90th percentile of 1,623 neurology providers in New York.

See all neurology providers in New York →

Medicare billing

Part B allowed, 2024

$10,289

Medicare patients

Services billed

122

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
IngrezzaValbenazine Tosylate	19	$179,858
Carbidopa-LevodopaCarbidopa/Levodopa	29	$844

Paid to pharmacies, not to this prescriber.

Other neurology in New York

Stephen KriegerNew York$1.1M
Sheng-Han KuoNew York$657K
Timothy VartanianNew York$468K
Steven WolfNew York$428K
David DodickNew York$426K
David SimpsonNew York$403K
Fred LublinNew York$383K
Alexander ShtilbansNew York$374K
Andrew LassmanNew York$359K
Brian ApatoffNew York$295K

See the full list for New York →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →